Dublin, Dec. 29, 2021 (GLOBE NEWSWIRE) -- The "Eye Care Surgical Market Research Report by Application, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Eye Care Surgical Market size was estimated at USD 3,276.23 million in 2020, is expected to reach USD 3,547.10 million in 2021, and projected to grow at a CAGR of 8.60% reaching USD 5,376.45 million by 2026.
Market Statistics
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage
This research report categorizes the Eye Care Surgical to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Application, the market was studied across Cataract Surgery, Corneal Surgery, Glaucoma Surgery, Oculoplastic Surgery, Refractive Surgery, and Vitreo-retinal Surgery.
- Based on End-user, the market was studied across Ambulatory Surgical Centers, Eye Research Institutes, Hospitals, and Ophthalmology Clinics.
- Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Competitive Strategic Window
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Eye Care Surgical Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Eye Care Surgical Market, including A.R.C. Laser GmbH, Abbott Laboratories Inc, Alcon Vision LLC, Avedro, Inc., Bausch & Lomb Incorporated, Beaver-Visitec International, Inc., Carl Zeiss Meditec AG, Essilor International S.A., Glaukos Corp, Hoya Corporation, iSTAR Medical SA, Lumenis Ltd, NIDEK CO., LTD., Novartis AG, Ophthalmic Instruments Inc., Optotune GmbH, RetinAI Medical GmbH, SENSIMED SA, Sight Sciences, Inc., Topcon Corporation, TRIOPTICS GmbH, Valeant Pharmaceuticals International Inc., and Virtual Expo Group.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Eye Care Surgical Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Eye Care Surgical Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Eye Care Surgical Market?
4. What is the competitive strategic window for opportunities in the Global Eye Care Surgical Market?
5. What are the technology trends and regulatory frameworks in the Global Eye Care Surgical Market?
6. What is the market share of the leading vendors in the Global Eye Care Surgical Market?
7. What modes and strategic moves are considered suitable for entering the Global Eye Care Surgical Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Rising prevalence of eye diseases
5.2.2. Technological advancements in eye surgical instruments
5.2.3. Increasing government initiatives to control visual impairment
5.3. Restraints
5.3.1. High cost of surgical instruments and lack of skilled professional
5.4. Opportunities
5.4.1. Rising development in advanced products and technologies
5.4.2. Increasing healthcare facilities in the emerging markets
5.5. Challenges
5.5.1. Lack of awareness and low accessibility to eye care in low-income economies
6. Eye Care Surgical Market, by Application
6.1. Introduction
6.2. Cataract Surgery
6.3. Corneal Surgery
6.4. Glaucoma Surgery
6.5. Oculoplastic Surgery
6.6. Refractive Surgery
6.7. Vitreo-retinal Surgery
7. Eye Care Surgical Market, by End-user
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Eye Research Institutes
7.4. Hospitals
7.5. Ophthalmology Clinics
8. Americas Eye Care Surgical Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Eye Care Surgical Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Eye Care Surgical Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, by Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. A.R.C. Laser GmbH
12.2. Abbott Laboratories Inc.
12.3. Alcon Vision LLC
12.4. Avedro, Inc.
12.5. Bausch & Lomb Incorporated
12.6. Beaver-Visitec International, Inc.
12.7. Carl Zeiss Meditec AG
12.8. Essilor International S.A.
12.9. Glaukos Corp
12.10. Hoya Corporation
12.11. iSTAR Medical SA
12.12. Lumenis Ltd.
12.13. NIDEK CO., LTD.
12.14. Novartis AG
12.15. Ophthalmic Instruments Inc.
12.16. Optotune GmbH
12.17. RetinAI Medical GmbH
12.18. SENSIMED SA
12.19. Sight Sciences, Inc.
12.20. Topcon Corporation
12.21. TRIOPTICS GmbH
12.22. Valeant Pharmaceuticals International Inc.
12.23. Virtual Expo Group
13. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/d56i6e
